VTv Total Assets vs Debt Current Analysis
VTVT Stock | USD 25.50 0.52 2.08% |
Trend analysis of vTv Therapeutics balance sheet accounts such as Total Assets of 10.5 M, Short Long Term Debt Total of 502.6 K, Other Current Liabilities of 5.9 M or Total Current Liabilities of 15 M provides information on VTv Therapeutics' total assets, liabilities, and equity, which is the actual value of vTv Therapeutics to its prevalent stockholders. By breaking down trends over time using VTv Therapeutics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
VTv |
About VTv Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of vTv Therapeutics at a specified time, usually calculated after every quarter, six months, or one year. VTv Therapeutics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of VTv Therapeutics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which VTv currently owns. An asset can also be divided into two categories, current and non-current.
VTv Therapeutics Balance Sheet Chart
VTv Therapeutics Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how vTv Therapeutics uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, VTv Therapeutics' Property Plant And Equipment Gross is comparatively stable compared to the past year. Total Current Assets is likely to gain to about 16.9 M in 2024, whereas Other Current Liabilities is likely to drop slightly above 5.9 M in 2024. Add Fundamental
Total Assets
Total assets refers to the total amount of VTv Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in vTv Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on VTv Therapeutics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of vTv Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from VTv Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into vTv Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.At this time, VTv Therapeutics' Issuance Of Capital Stock is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 11.59 in 2024, whereas Selling General Administrative is likely to drop slightly above 11.5 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 25.7M | 24.6M | 25.4M | 26.4M | Cost Of Revenue | 89K | 92K | 90K | 85.5K |
VTv Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
VTv Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
VTv Therapeutics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.3M | 14.8M | 25.5M | 33.2M | 11.0M | 10.5M | |
Short Long Term Debt Total | 7.1M | 915K | 932K | 716K | 529K | 502.6K | |
Other Current Liab | 4.8M | 4.2M | 8.1M | 4.9M | 6.2M | 5.9M | |
Total Current Liabilities | 13.4M | 6.4M | 8.5M | 7.7M | 10.6M | 15.0M | |
Total Stockholder Equity | (49.0M) | (80.1M) | (9.7M) | (10.7M) | (24.7M) | (25.9M) | |
Other Liab | 3.9M | 3.9M | 1.3M | 19.4M | 17.4M | 18.3M | |
Property Plant And Equipment Net | 1.0M | 849K | 680K | 556K | 361K | 343.0K | |
Net Debt | 5.3M | (4.8M) | (12.5M) | (11.4M) | (8.9M) | (8.5M) | |
Retained Earnings | (233.5M) | (290.0M) | (248.8M) | (265.5M) | (281.0M) | (295.1M) | |
Accounts Payable | 7.1M | 6.1M | 8.0M | 2.5M | 4.1M | 5.5M | |
Cash | 1.8M | 5.7M | 13.4M | 12.1M | 9.4M | 14.4M | |
Non Current Assets Total | 6.4M | 7.6M | 9.9M | 6.1M | 361K | 343.0K | |
Non Currrent Assets Other | 2.5M | 2.9M | (7.6M) | (6.1M) | (5.5M) | (5.3M) | |
Other Assets | 4.8M | 2.5M | 2.9M | 7.2M | 8.3M | 8.7M | |
Cash And Short Term Investments | 1.8M | 5.7M | 13.4M | 12.1M | 9.4M | 14.4M | |
Net Receivables | 5K | 158K | 57K | 12.4M | 102K | 96.9K | |
Common Stock Shares Outstanding | 757.3K | 1.2M | 1.5M | 1.9M | 2.1M | 2.0M | |
Short Term Investments | 250K | 371K | 100K | 15K | 65K | 61.8K | |
Liabilities And Stockholders Equity | 9.3M | 14.8M | 25.5M | 33.2M | 11.0M | 10.5M | |
Non Current Liabilities Total | 44.9M | 88.5M | 26.7M | 36.3M | 18.9M | 18.0M | |
Other Current Assets | 806K | 939K | 2.0M | 2.5M | 1.1M | 1.1M | |
Other Stockholder Equity | 183.9M | 209.2M | 238.2M | 253.7M | 256.3M | 163.5M | |
Total Liab | 58.3M | 94.9M | 35.2M | 44.0M | 29.6M | 28.1M | |
Property Plant And Equipment Gross | 1.0M | 367K | 680K | 556K | 848K | 1.1M | |
Total Current Assets | 2.8M | 7.2M | 15.6M | 27.1M | 10.7M | 16.9M | |
Short Term Debt | 6.3M | 239K | 440K | 378K | 360K | 342K | |
Property Plant Equipment | 1.0M | 367K | 680K | 207K | 186.3K | 177.0K | |
Net Tangible Assets | (49.0M) | 3.8M | (9.7M) | 5.8M | 6.7M | 7.1M | |
Short Long Term Debt | 6.2M | 84K | 256K | 224K | 191K | 181.5K | |
Common Stock Total Equity | 435K | 641K | 541K | 1.0M | 1.2M | 1.3M | |
Capital Surpluse | 150.6M | 183.9M | 209.2M | 253.7M | 291.8M | 183.4M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether vTv Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if VTv Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Vtv Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Vtv Therapeutics Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in vTv Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For more information on how to buy VTv Stock please use our How to Invest in VTv Therapeutics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for VTv Stock analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
CEOs Directory Screen CEOs from public companies around the world |
Is VTv Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VTv Therapeutics. If investors know VTv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VTv Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.71) | Revenue Per Share 0.004 | Return On Assets (0.72) | Return On Equity (49.78) |
The market value of vTv Therapeutics is measured differently than its book value, which is the value of VTv that is recorded on the company's balance sheet. Investors also form their own opinion of VTv Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is VTv Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VTv Therapeutics' market value can be influenced by many factors that don't directly affect VTv Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VTv Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if VTv Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VTv Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.